Skip to Content

Halofantrine Pregnancy and Breastfeeding Warnings

Halofantrine is also known as: Halfan

Halofantrine Pregnancy Warnings

Halofantrine has been assigned to pregnancy category C by the FDA. In rabbit studies, doses equivalent to 1.2 to 3.6 times the human dose were associated with skeletal malformations and abortion. Oral doses equivalent to 0.6 of the human dose did not cause maternal toxicity or fetotoxicity. In rats, oral doses equivalent to one-sixth of the human dose were associated with embryolethality and decreased fetal weight and viability. There are no controlled studies in human pregnancy. Halofantrine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

See references

Halofantrine Breastfeeding Warnings

There are no data on the excretion of halofantrine into human milk. In high-dose studies with rats, significant decreases in pup body weight and survival were observed. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Halfan (halofantrine)." GlaxoSmithKline, Philadelphia, PA.

References for breastfeeding information

  1. "Product Information. Halfan (halofantrine)." GlaxoSmithKline, Philadelphia, PA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.